Mirko Marabese
5PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 25, 2025
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma.Serena Petrella, Marika Colombo, Mirko Marabese
|Dec 11, 2022
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2).Marika Colombo, Federico Passarelli, Paola A Corsetto
|Aug 06, 2020
Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy.Maria Francesca Alvisi, Monica Ganzinelli, Helena Linardou
|Jul 29, 2020
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation.Elisa Caiola, Marika Colombo, Giovanna Sestito
|Aug 05, 2018
RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients.Anna Tessari, Kareesma Parbhoo, Meghan Pawlikowski
Pageof 1
Frequent Collaborators
4 joint publications
Massimo Broggini
3 joint publications
Marika Colombo
1 joint publications
Matteo Fassan
1 joint publications
Vincenzo Coppola
1 joint publications
Monica Lupi
1 joint publications
Maria Francesca Alvisi
1 joint publications
Anna Cecilia Bettini
1 joint publications
Paola A Corsetto
1 joint publications
Angela M Rizzo
1 joint publications
Roberta Pastorelli
